BriaCell Therapeutics Corp.(BCTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BCTX BriaCell Therapeutics Corp.

Trading 03-26 10:36:33 EDT

4.08

+0.03

+0.74%

High4.10	Low4.02	Vol20.57K
Open4.05	D1 Closing4.05	Amplitude1.98%
Mkt Cap29.58M	Tradable Cap26.45M	Total Shares7.25M
T/O83.59K	T/O Rate0.32%	Tradable Shares6.48M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BCTX","market":"US","secType":"STK","nameCN":"BriaCell Therapeutics Corp.","latestPrice":4.08,"timestamp":1774535543679,"preClose":4.05,"halted":0,"volume":20573,"delay":0,"changeRate":0.007407407407407469,"floatShares":6482500,"shares":7250500,"eps":-19.979195,"marketStatus":"Trading","change":0.03,"latestTime":"03-26 10:36:33 EDT","open":4.05,"high":4.1,"low":4.02,"amount":83591.370107,"amplitude":0.019753,"askPrice":4.11,"askSize":200,"bidPrice":4.06,"bidSize":118,"shortable":3,"etf":0,"ttmEps":-19.979195,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1774555200000},"marketStatusCode":2,"adr":0,"listingDate":1614142800000,"exchange":"NASDAQ","adjPreClose":4.05,"preHourTrading":{"tag":"盘前","latestPrice":4.24,"preClose":4.05,"latestTime":"09:25 EDT","volume":3981,"amount":16298.407078500002,"timestamp":1774531508492,"change":0.19,"changeRate":0.046914,"amplitude":0.069136},"postHourTrading":{"tag":"盘后","latestPrice":4.14,"preClose":4.05,"latestTime":"19:02 EDT","volume":2869,"amount":11798.0173,"timestamp":1774479723441,"change":0.09,"changeRate":0.022222,"amplitude":0.051852},"volumeRatio":0.68565,"impliedVol":0.6056,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/BCTX","defaultTab":"news","newsList":[{"id":"2620587842","title":"BriaCell to present four posters at the 2026 AACR","url":"https://stock-news.laohu8.com/highlight/detail?id=2620587842","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620587842?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:42","pubTimestamp":1773834175,"startTime":"0","endTime":"0","summary":"BriaCell (BCTX) Therapeutics announces that it will present four posters at the 2026 American Association for Cancer Research, or AACR, Annual Meet...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/briacell-to-present-four-posters-at-the-2026-aacr-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/briacell-to-present-four-posters-at-the-2026-aacr-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCTX","BK4139"],"gpt_icon":0},{"id":"2620255561","title":"BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2620255561","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620255561?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:30","pubTimestamp":1773833400,"startTime":"0","endTime":"0","summary":"PHILADELPHIA and VANCOUVER, British Columbia, March  18, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT)(“BriaCell” or the “Company”), a clinical-stage biotechnol","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/18/3258061/0/en/BriaCell-to-Present-Positive-Clinical-Data-for-Bria-IMT-and-Preclinical-Data-for-Next-Generation-Bria-OTS-Personalized-Immunotherapy-at-the-2026-AACR-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCTX"],"gpt_icon":0},{"id":"2618930581","title":"BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2618930581","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618930581?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:30","pubTimestamp":1773142200,"startTime":"0","endTime":"0","summary":"PHILADELPHIA and VANCOUVER, British Columbia, March  10, 2026  (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechn","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/10/3252671/0/en/BriaCell-to-Present-Four-Poster-Presentations-at-the-2026-AACR-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCTX"],"gpt_icon":0},{"id":"2618677120","title":"BriaCell Shareholders Approve Auditors and Reelect Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2618677120","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618677120?lang=en_us&edition=fundamental","pubTime":"2026-03-10 05:16","pubTimestamp":1773090972,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics ( ($TSE:BCT) ) has issued an announcement. On March 5, 2026, BriaCell Therapeutics Corp. held its Annual General and Special ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/briacell-shareholders-approve-auditors-and-reelect-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/briacell-shareholders-approve-auditors-and-reelect-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCTX","BK4139"],"gpt_icon":0},{"id":"2617711375","title":"BriaCell Shareholders Overwhelmingly Back Board and Auditors at Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2617711375","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617711375?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:53","pubTimestamp":1772747582,"startTime":"0","endTime":"0","summary":"The latest announcement is out from BriaCell Therapeutics ( ($TSE:BCT) ). BriaCell Therapeutics reported that 48.31% of its outstanding common shar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/briacell-shareholders-overwhelmingly-back-board-and-auditors-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/briacell-shareholders-overwhelmingly-back-board-and-auditors-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BCTX"],"gpt_icon":0},{"id":"2617576362","title":"BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2617576362","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617576362?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:04","pubTimestamp":1772744640,"startTime":"0","endTime":"0","summary":"PHILADELPHIA and VANCOUVER, British Columbia, March  05, 2026  (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechno","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/05/3250650/0/en/BriaCell-Therapeutics-Corp-Announces-Results-of-Shareholder-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTX","BK4139"],"gpt_icon":0},{"id":"2613290458","title":"BriaCell Restructures Soluble CD80 Program via BriaPro Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2613290458","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613290458?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:47","pubTimestamp":1771624057,"startTime":"0","endTime":"0","summary":"The latest announcement is out from BriaCell Therapeutics ( ($TSE:BCT) ). On February 18, 2026, BriaCell Therapeutics and its majority-owned subsid...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/briacell-restructures-soluble-cd80-program-via-briapro-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/briacell-restructures-soluble-cd80-program-via-briapro-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCTX","BK4139"],"gpt_icon":0},{"id":"2612427611","title":"BriaPro to purchase BriaCell’s license to develop, commercialize sCD80","url":"https://stock-news.laohu8.com/highlight/detail?id=2612427611","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612427611?lang=en_us&edition=fundamental","pubTime":"2026-02-19 06:35","pubTimestamp":1771454125,"startTime":"0","endTime":"0","summary":"BriaCell (BCTX) and its majority-owned subsidiary BriaPro Therapeutics announced that they have entered into a definitive purchase agreement pursua...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/briapro-to-purchase-briacells-license-to-develop-commercialize-scd80-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/briapro-to-purchase-briacells-license-to-develop-commercialize-scd80-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCTX","BK4139"],"gpt_icon":0},{"id":"2612452720","title":"BriaCell Therapeutics' Phase 3 Breast Cancer Treatment Trial Gets Fifth DSMB Recommendation to Continue","url":"https://stock-news.laohu8.com/highlight/detail?id=2612452720","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612452720?lang=en_us&edition=fundamental","pubTime":"2026-02-17 21:14","pubTimestamp":1771334096,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics  said Tuesday an independent data safety monitoring board has recommended for the fifth time continuation of a phase 3 study of its Bria-IMT plus an immune checkpoint inhibitor to treat metastatic breast cancer patients after reviewing safety data.The company said the board, which neets quarterly in accordance with the study protocol, reported no safety concerns and recommended the study continue without modifications.The trial is being conducted under a US Food and Drug Administration 'Fast Track' designation, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BCTX"],"gpt_icon":0},{"id":"2606716058","title":"BriaCell says patient images show regression, resolution of metastsized tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2606716058","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606716058?lang=en_us&edition=fundamental","pubTime":"2026-01-28 20:40","pubTimestamp":1769604040,"startTime":"0","endTime":"0","summary":"BriaCell (BCTX) Therapeutics releases new images highlighting resolution of metastatic breast cancer lesions in patients with orbital, temporal lob...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/briacell-says-patient-images-show-regression-resolution-of-metastsized-tumors-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/briacell-says-patient-images-show-regression-resolution-of-metastsized-tumors-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BCTX"],"gpt_icon":0},{"id":"2606781735","title":"BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2606781735","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606781735?lang=en_us&edition=fundamental","pubTime":"2026-01-27 20:30","pubTimestamp":1769517000,"startTime":"0","endTime":"0","summary":"9 of 25 BriaCell patients treated since 2022remain alive >18-47 months post enrollment, markedly exceeding benchmarks reported for standard of care therapies in similar patient populationsNo Bria-IMTr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/27/3226377/0/en/BriaCell-Highlights-Extended-18-47-Months-Survival-in-Phase-2-Metastatic-Breast-Cancer-Patients.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2065169927.USD","BK4129","LU2065171311.SGD","BCTX","LU2065170008.USD","TPC","LU2065171402.SGD"],"gpt_icon":0},{"id":"2603936253","title":"BriaCell Therapeutics Completes $30 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2603936253","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603936253?lang=en_us&edition=fundamental","pubTime":"2026-01-16 05:52","pubTimestamp":1768513958,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics ( ($TSE:BCT) ) has issued an update. On January 15, 2026, BriaCell Therapeutics Corp. closed a roughly $30 million best-effor...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/briacell-therapeutics-completes-30-million-public-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/briacell-therapeutics-completes-30-million-public-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BCTX"],"gpt_icon":0},{"id":"2603164526","title":"Crude Oil Gains Over 1%; US Retail Sales Rise 0.6% In November","url":"https://stock-news.laohu8.com/highlight/detail?id=2603164526","media":"Benzinga","labels":["economic","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603164526?lang=en_us&edition=fundamental","pubTime":"2026-01-15 01:41","pubTimestamp":1768412497,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ad4729b76724ee1369972c52e1f4f65c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/26/01/49914952/crude-oil-gains-over-1-us-retail-sales-rise-0-6-in-november","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QLD","USAW.SI","BK4185","BK4154","CLOV","QYLG","IVP","GPIQ","QQQE","MNQmain","PSTV","BCTX","BK4134","TSYW.SI","QID","BK4139","QQQJ",".IXIC","HUBC","IVPR","NQmain","SQQQ","BK4547","TQQQ","USJW.SI","QQQM","QQQY","PSQ","QYLD","NVIW.SI"],"gpt_icon":1},{"id":"2603128856","title":"US-Listed Shares of Briacell Therapeutics Tumble 55% After Co Prices $30 Mln Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2603128856","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603128856?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:31","pubTimestamp":1768401105,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nFWN3YF1XS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BCTX"],"gpt_icon":0},{"id":"2603615298","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2603615298","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603615298?lang=en_us&edition=fundamental","pubTime":"2026-01-14 20:52","pubTimestamp":1768395138,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics (BCTX) shares were 54% lower pre-bell Wednesday after the company launched a $30 million securities offering.Moolec Science (MLEC) stock was down 20%, reversing from gains from the previous session.IOThree (IOTR) shares were 18% lower, paring Tuesday's increase.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4212","BK4089","IOTR","BCTX","MLEC"],"gpt_icon":0},{"id":"2603836695","title":"BriaCell Therapeutics Prices $30 Million Public Offering of Stock, Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2603836695","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603836695?lang=en_us&edition=fundamental","pubTime":"2026-01-14 16:20","pubTimestamp":1768378804,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics  said late Tuesday it priced a public offering of 5.4 million units at $5.59 per unit for total expected gross proceeds of $30 million.Each unit consists of one common share and one warrant to purchase common shares at $6.93 per share. The company may also issue, in lieu of common shares, pre-funded warrants.Net proceeds will be used for working capital, general corporate purposes, and for the advancement of business objectives, BriaCell said.Closing of the offering is expected to occur this Thursday, subject to customary closing conditions.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BCTX"],"gpt_icon":1},{"id":"2603572376","title":"BriaCell Therapeutics Announces Pricing of $30 million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2603572376","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603572376?lang=en_us&edition=fundamental","pubTime":"2026-01-14 10:00","pubTimestamp":1768356000,"startTime":"0","endTime":"0","summary":"PHILADELPHIA and VANCOUVER, British Columbia, Jan.  13, 2026  (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechno","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/14/3218379/0/en/BriaCell-Therapeutics-Announces-Pricing-of-30-million-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCTX"],"gpt_icon":0},{"id":"2603638074","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:51 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2603638074","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603638074?lang=en_us&edition=fundamental","pubTime":"2026-01-13 22:51","pubTimestamp":1768315873,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:51 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nAQN2LHI1F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTX","BK4139"],"gpt_icon":0},{"id":"2603136638","title":"BriaCell Therapeutics trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2603136638","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603136638?lang=en_us&edition=fundamental","pubTime":"2026-01-13 22:35","pubTimestamp":1768314929,"startTime":"0","endTime":"0","summary":"09:32 EST BriaCell (BCTX) Therapeutics trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, mark...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/briacell-therapeutics-trading-halted-volatility-trading-pause-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/briacell-therapeutics-trading-halted-volatility-trading-pause-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCTX","BK4139"],"gpt_icon":0},{"id":"2603897166","title":"BriaCell reports sustained complete resolution of lung metastasis in Bria-OTS","url":"https://stock-news.laohu8.com/highlight/detail?id=2603897166","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603897166?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:35","pubTimestamp":1768307749,"startTime":"0","endTime":"0","summary":"BriaCell (BCTX) Therapeutics announces the durable and sustained complete resolution of a lung metastasis in a patient with metastatic breast cance...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/briacell-reports-sustained-complete-resolution-of-lung-metastasis-in-bria-ots-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/briacell-reports-sustained-complete-resolution-of-lung-metastasis-in-bria-ots-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BCTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://briacell.com","stockEarnings":[{"period":"1week","weight":-0.0603},{"period":"1month","weight":0.0771},{"period":"3month","weight":-0.4994},{"period":"6month","weight":-0.6332},{"period":"1year","weight":-0.901},{"period":"ytd","weight":-0.4304}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":-0.0375},{"period":"3month","weight":-0.0486},{"period":"6month","weight":-0.0076},{"period":"1year","weight":0.1414},{"period":"ytd","weight":-0.0368}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.124732},{"month":2,"riseRate":0.2,"avgChangeRate":-0.077389},{"month":3,"riseRate":0.666667,"avgChangeRate":0.066311},{"month":4,"riseRate":0.2,"avgChangeRate":-0.075667},{"month":5,"riseRate":0,"avgChangeRate":-0.209369},{"month":6,"riseRate":0.6,"avgChangeRate":0.078701},{"month":7,"riseRate":0.4,"avgChangeRate":-0.192928},{"month":8,"riseRate":1,"avgChangeRate":0.139099},{"month":9,"riseRate":0.6,"avgChangeRate":0.155119},{"month":10,"riseRate":0,"avgChangeRate":-0.140813},{"month":11,"riseRate":0.6,"avgChangeRate":0.110284},{"month":12,"riseRate":0.2,"avgChangeRate":-0.186609}],"exchange":"NASDAQ","name":"BriaCell Therapeutics Corp.","nameEN":"BriaCell Therapeutics Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BriaCell Therapeutics Corp.(BCTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BriaCell Therapeutics Corp.(BCTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BriaCell Therapeutics Corp.,BCTX,BriaCell Therapeutics Corp.股票,BriaCell Therapeutics Corp.股票老虎,BriaCell Therapeutics Corp.股票老虎国际,BriaCell Therapeutics Corp.行情,BriaCell Therapeutics Corp.股票行情,BriaCell Therapeutics Corp.股价,BriaCell Therapeutics Corp.股市,BriaCell Therapeutics Corp.股票价格,BriaCell Therapeutics Corp.股票交易,BriaCell Therapeutics Corp.股票购买,BriaCell Therapeutics Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BriaCell Therapeutics Corp.(BCTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BriaCell Therapeutics Corp.(BCTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}